Healthcare Services

Kidney Biopsy Market Projected To Surpass $2.86 Billion By 2030 At 4.7% CAGR

June 1, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Is The Expected Market Size Of The Kidney Biopsy Market In 2026 And How Much Will It Reach By 2030?

The kidney biopsy market size has shown strong growth in recent years. It is anticipated to expand from $2.26 billion in 2025 to $2.38 billion in 2026, with a compound annual growth rate (CAGR) of 5.4%. This past growth can be attributed to the rising prevalence of chronic kidney disease, an increasing incidence of glomerulonephritis and nephrotic syndrome, the established clinical reliance on renal biopsy for diagnosis, an increase in kidney transplant procedures, and the expansion of tertiary care hospitals.

The kidney biopsy market is projected to experience consistent growth over the coming years, with its size expected to reach $2.86 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 4.7%. This expansion during the forecast period is primarily driven by the escalating incidence of diabetes-related kidney conditions, the increased adoption of ultrasound- and CT-guided biopsy techniques, a heightened demand for early diagnosis of kidney diseases, continuous advancements in imaging technologies, and improved access to specialized nephrology care. Key trends anticipated in this period include a growing preference for minimally invasive kidney biopsy procedures, the rising utilization of image-guided percutaneous biopsies, an increasing need for accurate renal disease diagnosis, the broader application of biopsy procedures for transplant monitoring, and enhanced safety and precision in obtaining renal tissue samples.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=16458&type=smp

Which Core Factors Are Supporting The Expansion Of The Kidney Biopsy Market?

The escalating incidence of renal cancer is projected to stimulate the expansion of the kidney biopsy market in the foreseeable future. This condition is defined by the unrestrained multiplication of anomalous kidney cells. The increasing occurrence of renal cancer can be linked to elements like evolving lifestyles, environmental contaminants, and improved detection technologies that contribute to more diagnoses. A kidney biopsy is instrumental in diagnosing and overseeing renal cancer by verifying the existence of malignant cells, ascertaining the cancer’s grade, strategizing treatment, tracking how patients respond to therapy, and delivering information for prognosis. For instance, according to Cancer Research UK, new kidney cancer cases are anticipated to climb from approximately 16,300 in 2023 to about 21,900 in 2025. Thus, the growing incidence of renal cancer is a significant impetus behind the growth of the kidney biopsy market.

How Does Segment Analysis Break Down The Kidney Biopsy Market Structure?

The kidney biopsy market covered in this report is segmented –

1) By Type: Percutaneous Biopsy, Surgical Biopsy

2) By Indication: Kidney Failure, Kidney Transplant, Hematuria, Proteinuria

3) By End-User: Hospitals And Clinics, Tertiary Care Centers, Other End-Users

Subsegments:

1) By Percutaneous Biopsy: Ultrasound-Guided Biopsy, CT-Guided Biopsy

2) By Surgical Biopsy: Open Kidney Biopsy, Laparoscopic Kidney Biopsy

What Trends Are Affecting The Kidney Biopsy Market Dynamics?

Major companies engaged in the kidney biopsy market are developing advanced platforms by integrating artificial intelligence (AI) to improve diagnostic precision, optimize procedures, and enhance patient outcomes. Artificial intelligence (AI) elevates kidney biopsy by refining image analysis, offering diagnostic assistance, aiding in treatment formulation, providing predictive insights, and furthering research in kidney ailments. For example, in March 2024, Aiosyn, a software company headquartered in the Netherlands, introduced the NephroPath platform. The NephroPath platform utilizes computational pathology algorithms to examine histological biomarkers in kidney biopsies, including recognizing tissue types, quantifying interstitial fibrosis, and precisely counting and evaluating glomeruli. This AI-powered analysis guarantees uniform, comprehensive, and repeatable scoring of renal pathology biomarkers, addressing the deficiencies of conventional scoring approaches and observer bias.

Who Are The Companies Shaping The Kidney Biopsy Market Landscape?

Major companies operating in the kidney biopsy market are Cardinal Health, Medtronic plc, Siemens Healthineers AG, GE HealthCare Technologies Inc., Koninklijke Philips N.V., Becton Dickinson and Company, Boston Scientific Corporation, Olympus Corporation, Hitachi Ltd., Canon Medical Systems Corporation, Cook Medical, B. Braun Melsungen AG, Merit Medical Systems Inc., Argon Medical Devices Inc., Stryker Corporation, Integra LifeSciences Corporation, Leica Biosystems, Hologic Inc., Samsung Medison Co. Ltd., Mindray Medical International Limited, Terumo Corporation, Fujifilm Holdings Corporation

Access The Complete Kidney Biopsy Market Report:

https://www.thebusinessresearchcompany.com/report/kidney-biopsy-global-market-report

Which Region Stands As The Largest Contributor To The Kidney Biopsy Market?

North America was the largest region in the kidney biopsy market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the kidney biopsy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Kidney Biopsy Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/customise?id=16458&type=smp

Browse Through More Reports Similar to the Global Kidney Biopsy Market 2026, By The Business Research Company

Kidney Cancer Diagnostics And Therapeutics Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/kidney-cancer-diagnostics-and-therapeutics-global-market-report

Kidney Disease Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/kidney-disease-global-market-report

Liquid Biopsy Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/liquid-biopsy-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795